Bioanalytical Strategies for Peptide-Drug Conjugates (PDCs): Optimized Approaches for the Pharmaceutical Industry

The transition of a drug candidate molecule from discovery to clinical investigation is an important moment in any development program. Central to this...

The transition of a drug candidate from discovery to clinical trial application is one of the most high-stakes phases in drug development. Acute toxicity...